Here are five things to know:
1. The jury verdict for $142 million compensatory and $360 million punitive damages followed 37 days of testimony.
2. The trial, which consolidated cases involving five separate plaintiffs who are Texas residents, began Jan. 8.
3. The lawsuits, including those of more than 7,000 plaintiffs nationwide in the multidistrict litigation, claim that the DePuy implants were defective and caused metal debris to enter into patients’ bloodstreams. This allegedly caused severe injuries and sometimes led to revision surgery.
4. Plaintiffs’ attorneys also claim to have discovered several instances in which physicians lied in medical clinical testing of the devices and forged consent forms for patients who were using the product to lie about the results the patients experienced with the product.
5. The DePuy Pinnacle hip implants have not been recalled.
More articles on devices and implants:
Touch Surgery, Zimmer Biomet launch Oxford Partial Knee training — 4 points
Life Spine sales jump 45% in 6 months: 5 key notes
SpineGuard, OrthoPediatrics collaborate on pediatric spine technology: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
